Mexico Gene Amplification Technologies Market Size & Outlook

The gene amplification technologies market in Mexico is expected to reach a projected revenue of US$ 215.0 million by 2028. A compound annual growth rate of 0.6% is expected of Mexico gene amplification technologies market from 2022 to 2028.
Revenue, 2021 (US$M)
$206.6
Forecast, 2028 (US$M)
$215.0
CAGR, 2022 - 2028
0.6%
Report Coverage
Mexico

Mexico gene amplification technologies market highlights

  • The Mexico gene amplification technologies market generated a revenue of USD 206.6 million in 2021 and is expected to reach USD 215.0 million by 2028.
  • The Mexico market is expected to grow at a CAGR of 0.6% from 2022 to 2028.
  • In terms of segment, pcr-based amplification was the largest revenue generating technology in 2021.
  • Nucleic Acid Sequence Based Amplification (NASBA) is the most lucrative technology segment registering the fastest growth during the forecast period.


Gene amplification technologies market data book summary

Market revenue in 2021USD 206.6 million
Market revenue in 2028USD 215.0 million
Growth rate0.6% (CAGR from 2021 to 2028)
Largest segmentPcr-based amplification
Fastest growing segmentNucleic Acid Sequence Based Amplification (NASBA)
Historical data2018 - 2020
Base year2021
Forecast period2022 - 2028
Quantitative unitsRevenue in USD million
Market segmentationPCR-based Amplification, Loop Mediated Isothermal Amplification (LAMP), Nucleic Acid Sequence Based Amplification (NASBA), Strand Displacement Amplification (SDA), Multiple displacement amplification (MDA), Rolling Circle Amplification (RCA), Ramification amplification method (RAM)
Key market players worldwideQiagen NV, Illumina Inc, Bio-Rad Laboratories Inc, Silicon Laboratories Inc, Merck KGaA, Promega, Takara Bio Inc, Danaher Corp, New England Biolabs, 4Basebio, LGC Group, Vazyme Biotech, MyBiosource


Other key industry trends

  • In terms of revenue, Mexico accounted for 0.6% of the global gene amplification technologies market in 2021.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
  • In Latin America, Brazil gene amplification technologies market is projected to lead the regional market in terms of revenue in 2028.
  • Brazil is the fastest growing regional market in Latin America and is projected to reach USD 294.5 million by 2028.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Gene Amplification Technologies Market Companies

Name Profile # Employees HQ Website

Mexico gene amplification technologies market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gene amplification technologies market will help companies and investors design strategic landscapes.


Pcr-based amplification was the largest segment with a revenue share of 90.66% in 2021. Horizon Databook has segmented the Mexico gene amplification technologies market based on pcr-based amplification, loop mediated isothermal amplification (lamp), nucleic acid sequence based amplification (nasba), strand displacement amplification (sda), multiple displacement amplification (mda), rolling circle amplification (rca), ramification amplification method (ram) covering the revenue growth of each sub-segment from 2018 to 2028.


Being a developing economy, Mexico witnessed a number of challenges in implementing novel life science technologies in healthcare. These challenges include inadequate nutrition, limited resources, and lack of robust research network.

To amend this situation, several initiatives have commenced in the country that focus on detailed study of genetic makeup. In contrast, this scenario is set to change with the initiative of research studies on polymorphisms associated with common diseases in the country, thus providing a platform for creation of National Institute of Genomic Medicine (INMEGEN).

With the emerging biopharmaceutical industry in the country, the adoption of gene delivery technologies in the pharmaceutical industry is anticipated to witness lucrative growth in the coming years. Mexico is the second-largest pharmaceutical market in the Latin America region having significant growth potential.

Reasons to subscribe to Mexico gene amplification technologies market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Mexico gene amplification technologies market databook

  • Our clientele includes a mix of gene amplification technologies market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Mexico gene amplification technologies market , including forecasts for subscribers. This country databook contains high-level insights into Mexico gene amplification technologies market from 2018 to 2028, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Mexico gene amplification technologies market size, by technology, 2018-2028 (US$M)

Mexico Gene Amplification Technologies Market Outlook Share, 2021 & 2028 (US$M)

Mexico gene amplification technologies market size, by technology, 2018-2028 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more